Furthermore it was revealed that repackaging and reaffixing pharmaceuticals is permitted as long as it fulfills five provisions which have been named Bristol-Myers Squibb provisions.
Ennfremur kom í ljós að endurpökkun og endurmerking lyfja er heimil uppfylli hún fimm skilyrði sem nefnd hafa verið Bristol-Myers Squibb skilyrðin.